Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

How country-specific should a country-specific cost-effectiveness analysis be?

Publication ,  Journal Article
Reed, SD
Published in: Eur Heart J
January 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

January 2013

Volume

34

Issue

3

Start / End Page

166 / 167

Location

England

Related Subject Headings

  • beta-Alanine
  • Warfarin
  • Ticagrelor
  • Platelet Aggregation Inhibitors
  • Male
  • Humans
  • Female
  • Dabigatran
  • Cardiovascular System & Hematology
  • Benzimidazoles
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Reed, S. D. (2013). How country-specific should a country-specific cost-effectiveness analysis be? Eur Heart J, 34(3), 166–167. https://doi.org/10.1093/eurheartj/ehs204
Reed, Shelby D. “How country-specific should a country-specific cost-effectiveness analysis be?Eur Heart J 34, no. 3 (January 2013): 166–67. https://doi.org/10.1093/eurheartj/ehs204.
Reed, Shelby D. “How country-specific should a country-specific cost-effectiveness analysis be?Eur Heart J, vol. 34, no. 3, Jan. 2013, pp. 166–67. Pubmed, doi:10.1093/eurheartj/ehs204.
Journal cover image

Published In

Eur Heart J

DOI

EISSN

1522-9645

Publication Date

January 2013

Volume

34

Issue

3

Start / End Page

166 / 167

Location

England

Related Subject Headings

  • beta-Alanine
  • Warfarin
  • Ticagrelor
  • Platelet Aggregation Inhibitors
  • Male
  • Humans
  • Female
  • Dabigatran
  • Cardiovascular System & Hematology
  • Benzimidazoles